Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号

Headquarter Address: 8888 Lvyou Road, Jinan, Shandong 250104, CHINA Powered by www.300.cn

Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA

Author:
QILU PHARMACEUTICAL
Release time:
2018/08/13

Qilu Pharmaceutical announces that Piperacillin Sodium/Tazobactam Sodium for injection manufactured by its subsidiary Qilu Tianhe Pharmaceutical was approved by US FDA on August 13, 2018. The product was already approved in many countries, including the EU, Japan, Australia, Singapore, South Africa, etc.